Order Careers Contact Us Sign in Adaptive Biotechnologies Order Careers
Contact Us Sign in Immune Profiling Platform Platform OverviewPublications
Products & Services LIFE SCIENCES RESEARCHimmunoSEQ®CLINICAL
DIAGNOSTICSclonoSEQ®PipelineDRUG DISCOVERYCellular TherapyVaccines
PARTNERSHIPS Cancer Cellular TherapyAntigen MapBiopharma PartnershipsStrategic
Collaborators About Us Our StoryCultureCareersNewsroomContact Us Adaptive
Biotechnologies To Present At The 34th Annual J.P. Morgan Healthcare
Conference 01/06/2016 SEATTLE, Wa., January 6, 2016 – Adaptive
Biotechnologies, the leader in next generation sequencing (NGS) and expert
bioinformatics to profile T- and B-cell receptors of the adaptive immune
system, announced today that Chad Robins, President, Chief Executive Officer
and Co-founder, will present during the 34th Annual J.P. Morgan Healthcare
Conference on Tuesday, January 12, 2016 at 4:00 p.m. PST in San Francisco, CA.
Mr. Robins will share an update on the Company’s milestone achievements from
the past year, along with market opportunities and strategic objectives for
its research, diagnostic and therapeutic business areas for 2016 and beyond.
About Adaptive Biotechnologies® Adaptive Biotechnologies is the pioneer and
leader in combining high-throughput sequencing and expert bioinformatics to
profile T-cell and B-cell receptors. Adaptive is bringing the accuracy and
sensitivity of its immunosequencing platform into laboratories around the
world to drive groundbreaking research in cancer and other immune-mediated
diseases. Adaptive also translates immunosequencing discoveries into clinical
diagnostics and therapeutic development to improve patient care. CONTACT:
Adaptive Biotechnologies April Falcone 206-939-3835 media@adaptivebiotech.com
Previous Press Release Adaptive Biotechnologies and Collaborators Present New
Data Showing Minimal Residual Disease (MRD) Predicts Relapse and Survival in
Chronic Lymphocytic Leukemia (CLL) Patients 12/07/2015 Next Press Release
Pfizer Enters into Translational Research Collaboration with Adaptive
Biotechnologies to Help Advance Novel Immuno-Oncology Solutions 01/08/2016
Corporate/Research (855) 466-8667 Diagnostics (888) 522-8988 Immune Profiling
PlatformPlatform Overview Publications Products & ServicesLIFE SCIENCES
RESEARCH immunoSEQ® CLINICAL DIAGNOSTICS clonoSEQ® Pipeline DRUG DISCOVERY
Cellular Therapy Vaccines PartnershipsCancer Cellular Therapy Antigen Map
Biopharma Partnerships Strategic Collaborators About UsOur Story Culture
Careers News & Events Contact Us © Adaptive Biotechnologies. All Rights
Reserved. Terms of Use Online Privacy Policy Privacy Shield Policy HIPAA
Policy Code of Conduct Patents & Trademarks Licenses